Moreover, beyond its diagnostic abilities, PSMA PET/CT has also a prognostic value which has been clearly demonstrated in recurrent or metastatic disease settings but has not been studied well in localized and locally advanced PCa. This evidence concerns the gene FOLH1 and posterior cortical atrophy.